Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

2017 NCCN Annual Conference

Christina S. Chu, MD, of Fox Chase Cancer Center, discusses the link between human papillomavirus and genital cancers and what is known about the effect of HPV on treatment response and outcome.

David G. Pfister, MD, on HPV and Head and Neck Cancer

David G. Pfister, MD, of Memorial Sloan Ket...

Lymphoma

Leo I. Gordon, MD, on Hodgkin Lymphoma: Management Strategies

Leo I. Gordon, MD, of the Robert H. Lurie C...

Sarcoma

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Suzanne George, MD, of Dana-Farber Cancer I...

Hematologic Malignancies

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Ruben A. Mesa, MD, of the Mayo Clinic Cance...

Pancreatic Cancer

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Margaret A. Tempero, MD, of the UCSF Helen ...

Nov

Today In Oncology

Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

Related Videos

David G. Pfister, MD, on HPV and Head and Neck Cancer

Leo I. Gordon, MD, on Hodgkin Lymphoma: Management Strategies

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Immunotherapy Shows Strong Benefit in Two Gynecologic Cancers

Is There a Difference in Breast Cancer Recurrence Rates After Surgery With Regional vs General Anesthesia?

FDA Office of Hematology Oncology Products Reorganizes, Renamed Office of Oncologic Diseases

Secondary Analysis of TAILORx

ctDNA and Recurrence Risk After Surgery and Adjuvant Chemotherapy for Stage III Colon Cancer